News Industry News HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial August 10, 2015
News Industry News Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy June 16, 2015
Presentation TCT 2014 TCT 78: Predictors of Survival in Patients Undergoing Transcatheter Aortic Valve Closure for Significant Left Ventricular Assist Device-Associated Aortic Insufficiency Presenter: John C Criscione, Elmir Omerovic, Elizabeth Retzer September 16, 2014
News Conference News ESC 2012 Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension August 29, 2012